Skip to Main Content

Gibson talk

August 03, 2023
ID
10162

Transcript

  • 00:00Good afternoon everyone.
  • 00:02My name is Courtney Gibson and I'm an end
  • 00:06concern here at Yale New Haven Hospital.
  • 00:09So I'd like to thank the hyperparathyroidism
  • 00:12support and information group.
  • 00:14I'm headed by Rochelle for inviting me to
  • 00:17going to give a talk on you know general
  • 00:20aspects of primary hyperparathyroidism
  • 00:21and more specifically to answer the
  • 00:24many thoughtful question that you
  • 00:26questions that you all have sent in.
  • 00:28So I'm hoping to just give a brief
  • 00:31overview that I hope answer some
  • 00:33questions just about the disease
  • 00:35process itself and then we'll get
  • 00:37into some of the questions that
  • 00:38you have specifically asked.
  • 00:39So I'm going to go ahead and share
  • 00:42my screen here if I can do so.
  • 00:44Let's see here
  • 00:50Okay. All right.
  • 00:51So hopefully you all can see this.
  • 00:54So again, my name is Courtney Gibson and
  • 00:56I'm Associate Professor of Surgery here.
  • 00:59I'm an endocrine surgeon here at Yale
  • 01:01and I've been here for the past 10 years.
  • 01:03And today I just want to talk
  • 01:05about parathyroid disease.
  • 01:06What is it and how do we treat it?
  • 01:08I have no disclosures.
  • 01:10So first and foremost,
  • 01:12primary hyperparathyroidism,
  • 01:13which is the, you know,
  • 01:15the essence of our talk,
  • 01:16is the most common endocrine
  • 01:18disorder of all endocrine disorders
  • 01:20occurring in approximately one in 800
  • 01:22people in the United States alone.
  • 01:24And that number increases to one
  • 01:26in 250 women over the age of 60.
  • 01:29Although it can happen to any
  • 01:31gender at any age,
  • 01:32the male to female ratio is pretty
  • 01:35even under the age of 40 and increases
  • 01:37to about 4:00 to 1:00 on the female
  • 01:39side once you're over age 60.
  • 01:41There's approximately 100,000
  • 01:43cases diagnosed annually and
  • 01:45that's diagnosed cases.
  • 01:47And we do know that there is a common
  • 01:51underdiagnosis and misdiagnosis
  • 01:53that happens nationally and
  • 01:55internationally which leads to some
  • 01:57significant problems for patients.
  • 02:02So in general, you know what is
  • 02:04primary hyperparathyroidism.
  • 02:05It is over secretion of parathyroid
  • 02:08hormone by one or more parathyroid glands.
  • 02:11So under normal conditions, whatever
  • 02:12we eat or drink that has calcium in it,
  • 02:14our body stores the the calcium that we
  • 02:17need in our bones in our skeletal system.
  • 02:20And the excess amount largely
  • 02:22gets excreted in the urine.
  • 02:24And our when our parathyroid
  • 02:25glands are functioning normally,
  • 02:26this process happens pretty smoothly.
  • 02:28And that's why many of us,
  • 02:30many patients,
  • 02:30don't even know that they're
  • 02:32that parathyroid glands exist.
  • 02:34But somehow for unknown reasons,
  • 02:36one or more of these glands can
  • 02:38become autonomously functioning,
  • 02:39meaning they don't follow the
  • 02:42normal process of, you know,
  • 02:44calcium regulation and they
  • 02:46become overactive independently.
  • 02:47We do know that there's an association
  • 02:49between high doses of radiation exposure
  • 02:51in childhood and the onset of parent
  • 02:53thyroid disease later on in life.
  • 02:55But for the majority of these cases
  • 02:57that that history doesn't exist.
  • 02:59It's just a spontaneous event that happens
  • 03:01in an individual and when that happens,
  • 03:03there's an an excess hormone of
  • 03:05parathyroid hormone that gets secreted
  • 03:07and it tells the body to do things
  • 03:10that normally it shouldn't be doing.
  • 03:12So for example,
  • 03:13the kidneys are told to hold onto too
  • 03:15much calcium and so that's why patients
  • 03:17with primary hyperparathyroidism
  • 03:18are prone to develop kidney stones.
  • 03:21Along with that,
  • 03:22they tend to have polyuria or frequent
  • 03:24urination because the kidneys are
  • 03:26trying to get rid of the excess
  • 03:28calcium that is coming into the
  • 03:30collecting system and that can lead to,
  • 03:32you know,
  • 03:33excessive thirst or constant
  • 03:34feelings of dehydration.
  • 03:36The intestinal system also changes
  • 03:39when there's parathyroid hormone,
  • 03:41excess in the body.
  • 03:42And instead of getting revved
  • 03:44up like the kidneys do,
  • 03:45the intestines tend to slow down,
  • 03:47their motility slows down and there's
  • 03:50decreased peristalsis or movement
  • 03:52of intraluminal fluids and and
  • 03:54solids within the intestinal system
  • 03:57and that can lead to Constipation.
  • 03:59Constipation is something that can
  • 04:00happen to any of us at any given moment.
  • 04:03But when it's pretty consistent
  • 04:05or frequent Constipation in the
  • 04:07setting of hyperparathyrosism,
  • 04:09there definitely can be a
  • 04:10direct relationship there,
  • 04:13the bones, the skeletal system.
  • 04:15So this is as I mentioned earlier,
  • 04:17this is where most of our calcium is
  • 04:19stored under normal conditions and in
  • 04:21the setting of parathyroid disease.
  • 04:23This excess hormonal signal is telling
  • 04:25the bones that that there is a need to
  • 04:27release its calcium from the skeletal
  • 04:29system and it's the release of calcium
  • 04:32from the bones that leads to the rise in
  • 04:34serum calcium or calcium levels in the blood.
  • 04:37But at the same time,
  • 04:38it is also demineralizing the bones.
  • 04:40And so over time, patients can develop
  • 04:43bone disease such as osteoporosis,
  • 04:45which is the initial demineralization
  • 04:47of bones that is reversible.
  • 04:49But if gone unchecked and uncorrected,
  • 04:51that could lead to osteoporosis,
  • 04:52which is irreversible bone
  • 04:54loss in either case.
  • 04:56Parathyroid treatment of the
  • 04:58parathyroid disease is important.
  • 05:01In the case of Osteopenia,
  • 05:02that reversible bone loss can be
  • 05:04recovered completely in many cases,
  • 05:06whereas in osteoporosis,
  • 05:07those patients will go on to
  • 05:09likely need some sort of medical
  • 05:11treatment for their osteoporosis.
  • 05:13However,
  • 05:13the bone density can improve with
  • 05:16successful parathyroid treatment,
  • 05:17treatment of hyperparathyroidism.
  • 05:19And then lastly,
  • 05:20there's a phenomenon or condition called
  • 05:23neurocognitive dysfunction that is
  • 05:24associated with parathyroid disease.
  • 05:26That is very common syndrome or cluster
  • 05:29of symptoms that can include memory loss,
  • 05:33mental fogginess,
  • 05:34poor concentration,
  • 05:35fatigue out of proportion to
  • 05:37what one does every day and even
  • 05:40feelings of new onset or worsening
  • 05:42anxiety or depression that in the
  • 05:44setting of hyperparathyroidism we
  • 05:47call neurocognitive dysfunction.
  • 05:49So how do we diagnose or work
  • 05:52up this condition?
  • 05:53So what typically happens in the
  • 05:55classical setting is a patient is
  • 05:56found to have high calcium in their
  • 05:58blood either on routine blood work
  • 06:00or they present with some symptoms.
  • 06:01And that leads to, you know,
  • 06:03an investigation as to why
  • 06:04they're having the,
  • 06:05say for example,
  • 06:07severe fatigue or recurrent kidney stones.
  • 06:09And those patients are found to
  • 06:11have an elevated calcium level.
  • 06:12And then ultimately hopefully their
  • 06:14parathyroid hormone levels get checked
  • 06:16and that's also found to be elevated.
  • 06:18And that's what makes us kind
  • 06:20of lead to that diagnosis of
  • 06:23primary hyperparathyroidism.
  • 06:24So the work up of primary
  • 06:27hyperparathyroidism should start
  • 06:28with biochemical work up after a
  • 06:30patient presents with symptoms of
  • 06:33hyperparathyroidism or they are found
  • 06:35incidentally to have a high calcium level.
  • 06:38And that work up should include,
  • 06:39yes, the serum calcium,
  • 06:42an intact PTH level.
  • 06:44But other important biochemistry that
  • 06:47should be looked into is serum phosphate,
  • 06:50kidney function,
  • 06:52BU and creatinine levels and
  • 06:54vitamin D levels.
  • 06:55Some additional testing that
  • 06:57may be done as a 24 hour urinary
  • 06:59calcium as well as a PTHRP and
  • 07:01that's important we think of the
  • 07:03when we were thinking about the
  • 07:07differential of hypercalcemia.
  • 07:08So the spectrum of primary
  • 07:11hyperparathyroidism is,
  • 07:12you know,
  • 07:13there's classical primary hyperparathyroidism
  • 07:15where the calcium is elevated and
  • 07:18the parathyroid hormone is elevated.
  • 07:20And under normal conditions,
  • 07:21those two parameters should be
  • 07:23working in opposite directions.
  • 07:25And then there's subtypes
  • 07:26where the calcium may be in
  • 07:27the normal range,
  • 07:28but the parathyroid hormone is
  • 07:30persistently elevated and there's
  • 07:31no other reason to explain that
  • 07:33elevation in the parathyroid hormone.
  • 07:35There's also a normal hormonal
  • 07:38primary hyperparathyroidism where
  • 07:39the calcium is significantly elevated,
  • 07:42but the parathyroid hormone levels
  • 07:44remain quote UN quote within the normal
  • 07:46range and we call that an inappropriate
  • 07:49secretion of a type of a parathyroid
  • 07:51hormone in a setting of hypercalcemia.
  • 07:54So for example,
  • 07:54if a person has a calcium of 11 out
  • 07:57of the range of normal under normal
  • 07:59conditions that the parathyroid
  • 08:00glands are functioning normally,
  • 08:01we would expect the parathyroid
  • 08:02hormone level to be suppressed.
  • 08:04So the normal range of PTH
  • 08:05is between 10 and 70.
  • 08:07We would expect that patient have
  • 08:08a PTH somewhere around 10 or 20.
  • 08:10So if a patient has a calcium that's at
  • 08:12the upper end of normal or above normal,
  • 08:14say you know 10.511 or higher
  • 08:17and their PTH is 60,
  • 08:19although that technically
  • 08:20is within the normal range,
  • 08:21that's an inappropriate amount of
  • 08:23parathyroid hormone being secreted
  • 08:25given the high calcium level.
  • 08:26And so that qualifies or as as
  • 08:30primary hyperparathyroidism.
  • 08:31And then you know the most,
  • 08:33the more difficult cases to diagnose
  • 08:35would be the normal calcemic primary
  • 08:37hyperpara and the biochemically normal
  • 08:39primary hyperpara where both the
  • 08:41calcium and the PTH levels are normal.
  • 08:43But patients have symptomatology
  • 08:45consistent with primary hyperpara
  • 08:47thyroidism that cannot be explained
  • 08:50by other disease processes.
  • 08:51So in general,
  • 08:52the key to the diagnosis is
  • 08:54a nonsuppressive relationship
  • 08:55between calcium and PTH.
  • 08:57But there are subtypes that do
  • 08:59exist that we'll talk about when
  • 09:00we answer some of the questions.
  • 09:02It's important to note that
  • 09:03the degree of symptoms is not,
  • 09:05does not depend on calcium levels.
  • 09:07So sometimes patients are told that,
  • 09:09you know,
  • 09:10their calcium levels are mildly elevated.
  • 09:11But it's nothing to worry about because,
  • 09:13you know,
  • 09:14patients seemingly should feel fine.
  • 09:15And oftentimes, primary care doctors may,
  • 09:19you know,
  • 09:19overlook a serum calcium that's
  • 09:21elevated because in the grand scheme of
  • 09:23all the things that they're looking into,
  • 09:24a mildly elevated serum calcium
  • 09:27seems harmless.
  • 09:28But we definitely know from
  • 09:29experience and in the literature
  • 09:31that there are patients who are very
  • 09:33symptomatic even with minor elevations
  • 09:34in their serum calcium levels.
  • 09:35And there are those who have
  • 09:37very high serum calcium levels
  • 09:38that don't necessarily present
  • 09:39with significant symptoms.
  • 09:43Vitamin D levels are important to check,
  • 09:46as I mentioned, because you can
  • 09:49have a condition called secondary
  • 09:51hyperparathyroidism where the
  • 09:52parathyroid glands become overactive
  • 09:54because there's a vitamin D deficient
  • 09:56deficiency and that's an appropriate
  • 09:59overactivity of the parathyroid glands.
  • 10:01Once the vitamin D is corrected,
  • 10:02if that was the sole source
  • 10:04of the overactivity,
  • 10:05then we would expect the
  • 10:06parathyroid hormone to normalize.
  • 10:07But there are some cases where patients
  • 10:10have concomitant vitamin D deficiency
  • 10:12and primary hyperparathyroidism and
  • 10:14particularly in the United States where
  • 10:16we tend to avoid the sun, you know,
  • 10:19for fear of developing skin cancer.
  • 10:21Sunlight exposure is important for
  • 10:23conversion of vitamin D into the active
  • 10:26form that we need as human beings.
  • 10:28So many of us here in the United
  • 10:29States are vitamin D deficient
  • 10:31whether we know it or not and that
  • 10:32can lead to a mild elevation in
  • 10:34parathyroid hormone secretion.
  • 10:36But in patients who have that condition
  • 10:40along with primary hyperparathyroidism,
  • 10:41once you correct the vitamin D deficiency,
  • 10:43they still have persistent elevated
  • 10:45PTH levels consistent with
  • 10:47primary hyperparathyroidism.
  • 10:49It's important to note,
  • 10:51to rule that process in or out the vitamin
  • 10:54D has to be corrected and it takes
  • 10:56some time to correct vitamin D levels.
  • 10:58Sometimes it can take 8-8 weeks or
  • 11:01longer to get patients to normal
  • 11:03vitamin D levels on supplementation
  • 11:05and so patients need to be patient
  • 11:09in order to elucidate whether or not
  • 11:11there is an indeed a primary problem
  • 11:13with the parathyroid function or is it
  • 11:15solely due to the vitamin D deficiency.
  • 11:20So in general, there are
  • 11:25guidelines for indications for surgery
  • 11:27that you know that an international
  • 11:30workshop of parathyroid experts come
  • 11:33together every five to seven years ago,
  • 11:35five or seven years,
  • 11:36and come up with these guidelines.
  • 11:38And so these are just guidelines,
  • 11:39they're not set in stone.
  • 11:41So in general age under 50 years
  • 11:43was a guideline serum calcium
  • 11:45greater than 1 gram per deciliter,
  • 11:47bone mineral density,
  • 11:48you know consistent with osteoporosis or a
  • 11:52declining renal function as listed here.
  • 11:54Now these are guidelines for asymptomatic
  • 11:57patients with primary hyperparathyroidism.
  • 11:59Any patient who is symptomatic
  • 12:01should seek out surgical referral
  • 12:03or should be referred for surgical
  • 12:05management of their disease process.
  • 12:07And even the asymptomatic guidelines that
  • 12:09you know the guidelines are changing,
  • 12:11everchanging.
  • 12:12I do think we'll get to a point
  • 12:14where age will be off the table
  • 12:15because we certainly don't exclude
  • 12:17patients based on age of whether or
  • 12:18not they should receive surgery to
  • 12:20treat their parent thyroid disease.
  • 12:22And in fact most patients are
  • 12:23over the age of 50.
  • 12:25So the age under 50 doesn't make much sense.
  • 12:28So I do think that is a guideline
  • 12:30that will fall off in due time.
  • 12:34So localization studies are helpful when
  • 12:36we want to you do a targeted approach
  • 12:39and minimize the amount of surgery,
  • 12:41the amount of deception and
  • 12:42anesthesia needed.
  • 12:43But again,
  • 12:44localizations,
  • 12:45localization studies are after you have
  • 12:48confirmed that the patient has primary
  • 12:51hyperparathyroidism and to confirm
  • 12:54that the patient wants to have surgery.
  • 12:56So, you know, in the absence of that,
  • 12:58localization studies are unnecessary and
  • 12:59sometimes things are done out of order.
  • 13:02A patient gets an ultrasound done
  • 13:03before we even have a biochemical
  • 13:05confirmation of parathyroid disease.
  • 13:07And although most parathyroid glands
  • 13:08when they're normal in size and shape,
  • 13:10they're not visualized on imaging.
  • 13:12Some can be seen by,
  • 13:13you know,
  • 13:14a very astute radiologist may pick up a
  • 13:16parathyroid gland on an imaging study
  • 13:18and that can be a totally normal gland.
  • 13:20It does not mean that gland
  • 13:22needs to come out.
  • 13:22So we have to take a step back
  • 13:24and first of all confirm that that
  • 13:27patient indeed has biochemically
  • 13:29proven primary hyperparathyroidism.
  • 13:31But in terms of the localization studies
  • 13:33that we use in trying to identify
  • 13:36preoperatively abnormal parathyroid tissue,
  • 13:38here are some there,
  • 13:40there are many and the institution
  • 13:42specific here at our center,
  • 13:44we typically use an ultrasound in a 4D CT.
  • 13:47The ultrasound is used primarily to look
  • 13:49at the thyroid gland because in up to
  • 13:5120 to 30% of cases of parathyroid disease,
  • 13:53there may be a thyroid problem
  • 13:55like a thyroid nodule that needs
  • 13:56to be investigated further and
  • 13:58maybe even needs to be recepted.
  • 14:00So if a patient presents with
  • 14:01a thyroid nodule that needs
  • 14:03to undergo surgical resection,
  • 14:05we'd prefer to do that within one
  • 14:07surgical procedure instead of,
  • 14:08you know having to do 2 separate ones.
  • 14:09So that is the main utility of of of
  • 14:12doing an ultrasound preoperatively.
  • 14:15In some cases,
  • 14:16a large abnormal parathyroid gland
  • 14:17can be
  • 14:18detected on ultrasound and that's
  • 14:20also helpful and beneficial.
  • 14:21But if it's not, that doesn't mean
  • 14:23the patient doesn't have disease
  • 14:24because I refer you back to step one,
  • 14:26biochemically prove that
  • 14:27the patient has disease.
  • 14:29And then the next test that we use here is a
  • 14:33parathyroid specific CAT scan
  • 14:35called a 4G CT And we've compared
  • 14:37that with our cestomes that we've
  • 14:39done here and the sensitivity and
  • 14:41specificity of the four DCT is far
  • 14:43superior to that of the cestomes.
  • 14:45So our secondary study that more
  • 14:47specifically identifies and targets
  • 14:49abnormal parathyroid tissue is the
  • 14:514D CT and that's the combination
  • 14:53that we use here when we're
  • 14:54trying to plan for surgery.
  • 14:59Intraoperative measurement of PTH is
  • 15:00crucial if you have that available to you.
  • 15:03So just like the diagnosis of primary
  • 15:06hyperparathyroidism is based on biochemistry,
  • 15:08cure should be based on biochemistry,
  • 15:10and it is based on biochemistry.
  • 15:12So you are not considered to be cured
  • 15:14of your parathyroid disease even after
  • 15:16surgery until you're six months down
  • 15:18the line and your calcium vitamin DPTH
  • 15:20levels are checked again and they're
  • 15:22found to be in the normal range.
  • 15:24Now a nice surrogate is intraoperatively
  • 15:26if you can get normalization of the
  • 15:28parathyroid hormone by the end of
  • 15:30surgery then the chance of cure is
  • 15:33pretty significant, greater than 95%.
  • 15:34Meaning if you get the parathyroid hormone
  • 15:37levels normalize at the time of surgery,
  • 15:3995% of those patients will go on to have
  • 15:42curative disease cure of disease confirmed.
  • 15:44Six months down the line,
  • 15:47the half life of parathyroid
  • 15:48hormone is about four minutes.
  • 15:50So every, you know,
  • 15:513 1/2 to 5 minutes the PTH and in a person's
  • 15:55system is degrading by roughly 50%.
  • 15:58And this is very helpful because we
  • 16:01can get real time information on how
  • 16:04quickly the parathyroid function is
  • 16:06degrading at the time of surgery.
  • 16:08And then there's different criteria
  • 16:10that are used to have listed here
  • 16:11the Miami criteria and that says
  • 16:13that there should be a 50% decrease
  • 16:1510 minutes after you have surgical
  • 16:18resection that should be consistent
  • 16:20with cure of disease
  • 16:24at the time of surgery. Now I don't
  • 16:27specifically follow that criteria.
  • 16:28I do believe that there should be at
  • 16:30least a 50% drop in about 10 to 15
  • 16:32minutes after you feel like you resected
  • 16:35all the disease parathyroid tissue.
  • 16:37But in addition to that,
  • 16:38I want to see that drop remain
  • 16:39in the normal range,
  • 16:41you know for another two or three samples.
  • 16:43And I do that because some patients
  • 16:44come with a very elevated parathyroid
  • 16:46hormone at the time of surgery.
  • 16:48So they can have a PTH that's over 200
  • 16:50and normal range being between 10 and 70.
  • 16:53So let's say 15 minutes after I resected
  • 16:55a big and large parathyroid gland,
  • 16:57the the PTH drops from 200 to 100.
  • 17:00That's encouraging.
  • 17:01But that 100 is still elevated and I don't
  • 17:04want to end my case with an elevated PTH.
  • 17:06So I want to see that that is going
  • 17:08to continue to drop down and get down
  • 17:09into the normal ranges and then level
  • 17:11off and then and then low normal
  • 17:12range somewhere around 30 or so.
  • 17:15So that's why I always send extra
  • 17:17samples or have the anesthesia,
  • 17:18I'll just send a few extra samples once
  • 17:20we get a normal value to make sure
  • 17:22that it's not starting to rise again,
  • 17:23which would suggest that there's
  • 17:26more disease present than what
  • 17:28the preoperative imaging shows.
  • 17:29And that happens sometimes.
  • 17:33We have,
  • 17:35I'm sorry, so the differentiation of
  • 17:38hyperparathyroidism, just briefly,
  • 17:39you know, the difference between primary,
  • 17:41secondary and tertiary has to do with
  • 17:44what is the insult that is causing
  • 17:47the parathyroid to become overactive.
  • 17:49So in primary hyperparathyroidism,
  • 17:51there is no insult.
  • 17:52These glands start autonomously
  • 17:54functioning and there's not a secondary
  • 17:56cause that's making them do so.
  • 17:57So the primary problem is with
  • 17:59the parathyroid function of
  • 18:00parathyroid tissue itself.
  • 18:02And in those cases,
  • 18:03in the classical case,
  • 18:04serum calcium is elevated,
  • 18:06parathyroid hormone is elevated and
  • 18:08vitamin D should be normal or elevated.
  • 18:10In secondary hyperparathyroidism.
  • 18:11There's a secondary cause as to
  • 18:14why the parathyroid glands are
  • 18:16over functioning and that secondary
  • 18:18cause can be a vitamin D deficiency
  • 18:20like we talked about earlier or
  • 18:22it can be kidney dysfunction like
  • 18:23end stage renal disease.
  • 18:25And so that's where the other levels
  • 18:27like checking the creatinine and
  • 18:29phosphate levels are important.
  • 18:30So in secondary Hyperpara patients
  • 18:34have overactivity of their parathyroid
  • 18:36glands because they have high serum
  • 18:38phosphate levels and low vitamin D
  • 18:40levels because of their kidney failure.
  • 18:43And the parathyroid glands don't
  • 18:44know that the kidneys have failed.
  • 18:45So they are overactive and revved
  • 18:47up trying to get the kidneys to
  • 18:49release the excess phosphorus,
  • 18:50which cannot happen in the setting
  • 18:52of kidney failure.
  • 18:53And then tertiary hyperparathyroidism
  • 18:56happens after prolonged secondary
  • 18:58hyperparathyroidism that has
  • 18:59been left untreated.
  • 19:00And so this happens usually in two settings,
  • 19:03either a patient who has instage renal
  • 19:06disease and secondary hyperparathyroidism
  • 19:08that just goes on untreated for many,
  • 19:11many years.
  • 19:12And so their calcium ultimately
  • 19:13begins to rise as if they are
  • 19:16someone with primary hyperpara.
  • 19:17That's one case.
  • 19:18The other case is a patient who
  • 19:20successfully got a kidney transplant when
  • 19:23they had secondary hyperparathyroidism.
  • 19:24And despite now having
  • 19:26normal kidney function,
  • 19:27those glands have been autonomously
  • 19:29functioning for quite some time and they
  • 19:31have not fully gone back to normal.
  • 19:33And so that is tertiary hyperpara
  • 19:35and those patients usually go
  • 19:37on to surgical treatment of
  • 19:38their hyperparathyroidism.
  • 19:39But that's beyond the scope of
  • 19:41what we're going to discuss today.
  • 19:43So we can skip over these
  • 19:47Okay. So basically talked about
  • 19:49secondary inter sharing. All right.
  • 19:52So I am going to stop sharing now and
  • 19:56let's see if I can get to the important
  • 20:02questions that you guys have asked.
  • 20:06Okay, I'm going to pull them up here.
  • 20:10All right. And so for the remainder
  • 20:12of our time here, I'm just going
  • 20:13to get through as many as I can.
  • 20:16Some of them are repetitive questions,
  • 20:19so that's good. That means there's,
  • 20:20you know, high interest in that question.
  • 20:22Hopefully I can get to those.
  • 20:23So let's see.
  • 20:24So the first question is some
  • 20:26surgeons hesitate to operate on
  • 20:28patients presenting with normal
  • 20:29calcemic hyperparathyroidism because
  • 20:30they claim that the surgery will
  • 20:33not benefit them in the long run.
  • 20:34What would be the criteria for you
  • 20:36to be doubtful about accepting a
  • 20:38normal calcemic patient for surgery?
  • 20:40This is a very good question and
  • 20:43it's you know normal calcemic
  • 20:45primary hyperparathyroidism is a
  • 20:47very controversial topic and it's
  • 20:49not so much controversial in this
  • 20:51in those of us who are what have a
  • 20:53lot of experience in dealing with
  • 20:55primary hyperparathyroidism and
  • 20:56the surgical management of them.
  • 20:59So we are not unclear about the diagnosis.
  • 21:01We definitely believe that this entity
  • 21:03exists where you can have normal
  • 21:05calceming primary hyperparathyroidism.
  • 21:07The controversy or the confusion
  • 21:09lies in what to do about that.
  • 21:11So in classical case primary
  • 21:15hyperparathyroidism,
  • 21:16most patients have single gland disease.
  • 21:18You remove that one gland,
  • 21:20the problem is solved and the remaining
  • 21:22three healthy glands will eventually
  • 21:23wake up and function at a normal level.
  • 21:25But even in the setting where you have
  • 21:28primary hyperparathyroidism and all
  • 21:29four glands are disease and we have
  • 21:31to perform what's called a subtotal
  • 21:33parathyroid resection where we remove
  • 21:35the majority of your parathyroid tissue.
  • 21:37We are comfortable as surgeons and
  • 21:39confident that even removing the bulk
  • 21:41of that tissue we're not going to leave
  • 21:43give you permanently hypocalcemic
  • 21:44and we have a a bigger window of
  • 21:46opportunity to allow the calcium to drop.
  • 21:48So most of those patients
  • 21:50are already hypercalcemic.
  • 21:52So their calcium levels are well over 10,
  • 21:54sometimes over 11 and 12.
  • 21:56And after we remove you know that
  • 21:58that disease parathyroid tissue that
  • 21:59serum calcium is going to drop,
  • 22:01it's going to ultimately land
  • 22:02in the normal level,
  • 22:03but sometimes it'll overshoot
  • 22:05and it'll be in the low,
  • 22:06you know it'll be low and not normal.
  • 22:08And those patients can present
  • 22:10with pretty significant symptoms
  • 22:12of muscle aches and pains,
  • 22:14numbness and tingling and they will need
  • 22:16some calcium supplementation for a time.
  • 22:18So we are understanding of that as
  • 22:23as parathyroid doctors and surgeons
  • 22:27and we properly prepare our patients
  • 22:30to experience that and let them
  • 22:32know that that those symptoms should
  • 22:33persist for days maybe you know a
  • 22:35week or two but should subside.
  • 22:37When we're talking about normal calcium,
  • 22:38the primary hyperparathyroidism,
  • 22:39the problem is we don't have that
  • 22:42much of A window of opportunity.
  • 22:43Those patients already have calcium
  • 22:45that are that's normal.
  • 22:47So we're talking about a calcium that is,
  • 22:48you know, 99.5 sometimes even you know,
  • 22:51high eights. And we and also many
  • 22:54of those patients need a subtotal
  • 22:57resection because there's a higher
  • 22:58incidence of multigland hyperplasia
  • 23:00where all four glands are diseased.
  • 23:02And so taking out one is not going to
  • 23:04solve the problem in patients who have
  • 23:06normal calcemic primary hyperparathyrosism.
  • 23:08So not only are we having to perform
  • 23:12a potential subtotal resection
  • 23:13in these patients,
  • 23:14we have a lower window at of where
  • 23:17that calcium can safely drop.
  • 23:19So you're starting out already
  • 23:20normal and not high and now you're
  • 23:21definitely going to be low for a
  • 23:23while and that can be a long while,
  • 23:25prolonged while.
  • 23:25And so those patients can end up pretty
  • 23:28symptomatic and and initially feel a
  • 23:30lot worse than they did just having the
  • 23:32normal calcium and primary Hyperpara.
  • 23:34So for those reasons you know individual
  • 23:37surgeons have come up with different
  • 23:40criteria that they need met in order
  • 23:42to offer surgery to those patients
  • 23:44and it's really in an effort to do
  • 23:46good and not harm in those patients.
  • 23:49We don't have enough data yet to
  • 23:53say consistently which patients with
  • 23:55normal calcemic hyperparathyroidism
  • 23:56are going to benefit from surgery.
  • 23:58Now me personally I like to have
  • 24:00some hard evidence that the patients
  • 24:02are have significant symptoms of
  • 24:04parathyroid disease and by that
  • 24:05I mean evidence of bone disease.
  • 24:07So osteopenia,
  • 24:08osteoporosis,
  • 24:08evidence of kidney disease like kidney
  • 24:11stones that have been clinically
  • 24:13significant or at least they are
  • 24:16detectable on a kidney ultrasound.
  • 24:18So that's those are things that
  • 24:19we know treating the parathyroid
  • 24:21disease will treat those symptoms
  • 24:23or improve those symptoms.
  • 24:25So we can,
  • 24:26we definitely know that treating parathyroid
  • 24:28disease and curing it improves bone health.
  • 24:30It decreases your risk of
  • 24:32developing kidney stones.
  • 24:33What's less tangible or for lack
  • 24:35of a better term or harder to show
  • 24:39is the neurocognitive symptoms.
  • 24:41So you know,
  • 24:42neurocognitive symptoms such as fatigue,
  • 24:45memory loss, anxiety,
  • 24:47depression is often multifactorial.
  • 24:50And while parathyroid disease definitely
  • 24:52can can significantly contribute to that,
  • 24:55it's often not the sole source of
  • 24:57those neurocognitive symptoms.
  • 24:58And so if we, you know,
  • 24:59offer surgery to patients with normal
  • 25:02calcemic primary hyperparathyroidism
  • 25:04who only have the neurocognitive
  • 25:06symptoms and then we end up having
  • 25:09to do something like a subtotal
  • 25:10resection in that patient.
  • 25:12They may still have some ongoing
  • 25:15neurocognitive symptoms and on
  • 25:17top of that can have some pretty
  • 25:19significant hypocalcemic symptoms.
  • 25:21And and can also ultimately end
  • 25:23up being permanently hypoparent
  • 25:25thyroid instead of hyperparathyroid
  • 25:26where they just don't make enough
  • 25:28parathyroid hormone anymore and
  • 25:30they're chronically low.
  • 25:31And it's also not good for bone health.
  • 25:33So it's not a simple decision to
  • 25:35make when patients have normal
  • 25:36calcium and primary hyperpara.
  • 25:37Me personally,
  • 25:38I've operated on many patients who have
  • 25:41that particular subtype of primary
  • 25:43hyperpara and usually my criteria are,
  • 25:46I do want to see some solid
  • 25:48evidence of symptomatology that I
  • 25:49feel is correctable with surgery.
  • 25:51So kidney stones, bone disease,
  • 25:54severe fatigue out of proportion to
  • 25:56what you would expect in in a particular
  • 25:59patient that is a that's an additional one.
  • 26:03You know that alone sometimes I've
  • 26:06been you know persuaded to operate
  • 26:08but many times not and and also a
  • 26:11starting calcium that is at least
  • 26:14you know mid nines 95 or so some 9-3.
  • 26:17But if the your if your calcium is 899.0
  • 26:22and there is you know no strong hard
  • 26:26signs of parathyroid disease manifestations,
  • 26:30then I usually you know just ask
  • 26:32the patient to bear bear with me
  • 26:34and their endocrinologist and let's
  • 26:35trend things over time.
  • 26:37See if the parathyroid function worsens
  • 26:39or if the calcium level start to rise
  • 26:41to a safer level where we can then do
  • 26:43potentially A subtotal resection and
  • 26:45not leave them permanently hypocalcemic
  • 26:46because that's a terrible condition to have.
  • 26:49You may know some people who
  • 26:51have that condition okay,
  • 26:52So that's a lot of time spent
  • 26:53on that first question,
  • 26:54but I think it's important.
  • 26:55There were many of you who
  • 26:56had questions about that
  • 26:59interoperative PTH testing.
  • 27:01Here's another question.
  • 27:02From what I've understood,
  • 27:03there seems to be a greater
  • 27:05possibility of a normal calcemic
  • 27:06patient having multi gland disease.
  • 27:07In your opinion, how important is
  • 27:09interoperative PTH testing in such cases?
  • 27:11Or could bilateral expiration
  • 27:13be a wise alternative when
  • 27:15interoperative PTH is not available,
  • 27:17so interoperative PTH testing is
  • 27:20to me it is crucial and imperative
  • 27:23when you have that available to you.
  • 27:26So whether you have primary
  • 27:28hyperparathyroidism,
  • 27:28the classic case or normal
  • 27:30hormonal or normal Calcemic,
  • 27:32primary Hyperpara,
  • 27:33the Interopter PTH monitoring is very,
  • 27:35extremely beneficial.
  • 27:36And I, you know,
  • 27:37recommend that it be utilized in
  • 27:39all cases where it's available.
  • 27:41As we talked about earlier,
  • 27:43there's an expected decline
  • 27:45in parathyroid hormone levels
  • 27:46in every 5 minutes or so.
  • 27:48And so that gives us very useful
  • 27:51information of when we can stop the
  • 27:53case and and be confident that we
  • 27:55have resected all relevant disease
  • 27:57when it comes to the parathyroid.
  • 27:58So it's really important to do a
  • 28:00trial for PTH monitoring that when
  • 28:02that is not available then yes,
  • 28:04those patients should go on to
  • 28:06to have a four gland exploration.
  • 28:08So identifying all four parathyroid glands
  • 28:11and removing the glands that look enlarged.
  • 28:14But we know that as
  • 28:16clinicians that's not ideal.
  • 28:17The surgeon's eye.
  • 28:18You know,
  • 28:19although we are confident in our eyes,
  • 28:20and many of us wear magnification,
  • 28:23literature and studies have shown
  • 28:25that surgeon's eye alone is not
  • 28:28adequate in routinely accurately
  • 28:32determining which glands are abnormal.
  • 28:35And that's because there could be
  • 28:36subtle changes in the parenthetic
  • 28:38gland that even a magnified eye
  • 28:40don't doesn't see at quite as well.
  • 28:42So a normal gland is about the
  • 28:43size of a grain of rice and has
  • 28:46a elongated Oval like shape.
  • 28:47When parasitic glands become
  • 28:49overactive often times they get
  • 28:51larger and rounder and plump and
  • 28:52sometimes that that size can get to
  • 28:54the size of a grape or even larger.
  • 28:56But many times particularly when you're
  • 28:58talking about multi gland disease,
  • 28:59these glands are about the
  • 29:00same size and shape.
  • 29:01There may be some very subtle changes
  • 29:03in the size and shape of them and so
  • 29:05that's where the hormone plays a role.
  • 29:07So if a patient has nonlocalizing
  • 29:10preoperative imaging that already
  • 29:11kind of increases my thought process
  • 29:13in or my suspicion that that patient
  • 29:16may have multi gland disease or
  • 29:18if they have an ultrasound that
  • 29:19suggests that there's one enlarged
  • 29:20gland on the right hand side behind
  • 29:22the thyroid and a CAT scan that says
  • 29:23they see something on the left,
  • 29:25then that's what we call discordant
  • 29:26imaging and there's a higher incidence
  • 29:28of multigland disease in those cases.
  • 29:30So I think interrupter PTH is important
  • 29:32in all parathyroid surgery when it's
  • 29:34available and when it's not available,
  • 29:36yes, for gland exploration should be done.
  • 29:40Let's see here,
  • 29:43there is a lot of confusion about
  • 29:44calcium intake before surgery.
  • 29:46Some endocrinologists say to
  • 29:47take supplements,
  • 29:47other doctors say to hold calcium.
  • 29:49The guidelines from the 5th
  • 29:51International workshop say to
  • 29:52get the recommended daily amount.
  • 29:53Can you please comment on this?
  • 29:55So yes,
  • 29:56I I do agree with the the guidelines
  • 29:59from the international workshop of
  • 30:01getting your recommended daily amount
  • 30:03and that's what basically can be
  • 30:05taken care of with just an over over
  • 30:07counter calcium supplementation.
  • 30:08The high level calcium and vitamin
  • 30:10D supplementation that patients need
  • 30:12after surgery is a different amount
  • 30:14or different dosing of calcium.
  • 30:16Now some endocrinologists want patients
  • 30:20to hold their calcium preoperatively
  • 30:23so that they don't worsen the serum
  • 30:26hypercalcemia that the patients have.
  • 30:28And others feel that is not necessary
  • 30:29and they're more more concerned
  • 30:30about the bone health and the
  • 30:32expected hypocalcemia after surgery
  • 30:34that could become symptomatic.
  • 30:36So they want patients to be on calcium.
  • 30:39In my experience,
  • 30:40I think
  • 30:43continuing your calcium supplementation
  • 30:45is perfectly reasonable except for
  • 30:47those patients who already have very
  • 30:49high serum calcium before surgery,
  • 30:51surgery and they're very symptomatic.
  • 30:53So patient has like a calcium of 12 or 13.
  • 30:55They don't need any additional dietary
  • 30:58calcium intake because that can worsen
  • 31:00just how they're feeling in general.
  • 31:02But those who you know,
  • 31:03have a mild elevation,
  • 31:04you know, 11 or less,
  • 31:05taking their daily supplement as
  • 31:06long as it doesn't worsen how they're
  • 31:08feeling is reasonable because we
  • 31:09know that we're going to be getting
  • 31:11them to surgery and that the calcium
  • 31:12levels will drop and they are going to
  • 31:14need some supplementation until the
  • 31:16normal parathyroid glands kick in and
  • 31:18start functioning at a normal level.
  • 31:19So Long story short,
  • 31:20I think it's reasonable to take
  • 31:22your daily dietary intake.
  • 31:24If you find that your symptoms are worsening,
  • 31:26then stop the calcium but contain the
  • 31:27vitamin D would be my recommendation.
  • 31:29But I would defer to what your
  • 31:31endocrinologist are recommending for you.
  • 31:34Okay
  • 31:40can you have normal hormonal primary
  • 31:43hyperparathyrosism when your calcium
  • 31:45and PTH levels bounce around the range
  • 31:47of PTH being 19 to 66 in my case.
  • 31:49And so yes, your calcium
  • 31:52and PTH levels do fluctuate.
  • 31:54Whether you have the classical
  • 31:56case of primary hyperparathyrosism,
  • 31:57you know your calcium is not
  • 31:58always going to be 11.
  • 31:59It usually is always elevated in
  • 32:01those cases but maybe not exactly
  • 32:03you know 11 when you have normal
  • 32:05hormonal primary hyperparathyroidism
  • 32:07the calcium levels will fluctuate some
  • 32:09as well too and but that's why it's
  • 32:11important to exclude other sources of
  • 32:13the hyperparathyroidism in that case.
  • 32:15So you want to make sure that that
  • 32:16patient doesn't truly have a vitamin
  • 32:18D deficiency that's causing the
  • 32:20hyperparathyroidism and not normal
  • 32:22hormonal primary hyperparathyroidism.
  • 32:23So normal hormonal primary
  • 32:26hyperparathyroidism is a diagnosis
  • 32:28of exclusion.
  • 32:29So you have to exclude all of the
  • 32:31reasons to have hyperparathyroidism
  • 32:32and all your left with is this subtype
  • 32:34of normal hormonal and that's why
  • 32:36it's really important to investigate
  • 32:38for kidney dysfunction and vitamin
  • 32:39D deficiency in those patients.
  • 32:45I would love to know why children
  • 32:47without genetic conditions like
  • 32:49multiple endocrine neoplasia or end
  • 32:51up with primary hyperparathyrosome.
  • 32:53I think that's a great question.
  • 32:55You know, like many diseases
  • 32:57that are common in adults,
  • 32:59there are some that present in
  • 33:01childhood that we just don't don't
  • 33:03understand fully why that happens.
  • 33:04So yes, I've operated on kids who have
  • 33:07had primary hyperparathyrosome and most
  • 33:09of those kids do not have a genetic
  • 33:11syndrome that has predisposed them to that.
  • 33:14So we really don't know why it happens,
  • 33:17but it is found in children,
  • 33:18not very frequently, but it does occur.
  • 33:22What is the current status for parathyroid
  • 33:24transplants using the patient's own tissue?
  • 33:26Is this widely practiced
  • 33:28and how successful is it?
  • 33:30OK, so this is this question is
  • 33:32kind of asking about parathyroid
  • 33:34transplantation after a subtotal resection,
  • 33:37or at least that's how I'm taking it as.
  • 33:39So there are two trains of thought when
  • 33:41you're dealing with parathyroid disease.
  • 33:43There's those who perform a subtotal
  • 33:46parathyroidectomy where they remove 3
  • 33:48to 3 1/2 of the four glands leading,
  • 33:50leaving a portion of the remaining gland
  • 33:53intact with its natural blood supply.
  • 33:55And there are those who perform
  • 33:57a total thyroidectomy,
  • 33:59an auto transplant,
  • 34:01A portion of parathery tissue in the
  • 34:04forearm that's that is a parathery
  • 34:06transplant transplant of the patient's
  • 34:08own parathery tissue and there's
  • 34:10pluses and minuses of both camps.
  • 34:12So in the subtotal resection,
  • 34:15the argument is that you are leaving
  • 34:17that a portion of that gland right in
  • 34:19its natural element where it's always
  • 34:21been with its intact blood supply.
  • 34:23So you know that it will have some
  • 34:25function and produce parathyroid hormone.
  • 34:27And the and many proponents,
  • 34:29many surgeons who are in favor of
  • 34:31that like to see that they intact
  • 34:34intec vascular supply is is maintained
  • 34:36in those cases.
  • 34:38And so I fall into that category.
  • 34:40I prefer performing a subtotal resection.
  • 34:42There are those in the camp of performing
  • 34:45a total thyroidectomy who feel that
  • 34:47I'm sorry total parathyroidectomy
  • 34:49and they do so because they feel that
  • 34:51all four of the glands are diseased.
  • 34:53So in the event that the
  • 34:55remaining parathyroid gland,
  • 34:57a portion of parathyroid gland,
  • 34:58becomes overactive and causes
  • 35:00of recurrence of disease,
  • 35:01it's easier to open up the forearm
  • 35:03and resect that tissue again than it
  • 35:05is to go back into the neck where the
  • 35:08recurrent laryngeal nerves lie and
  • 35:10where there's a higher risk of injury
  • 35:12to more important structures in the neck.
  • 35:14And I would say that in the hands of an
  • 35:17experienced parathyroid surgery surgeon,
  • 35:19going back into the neck,
  • 35:21yeah,
  • 35:21the risk is higher than if you've
  • 35:23never had surgery.
  • 35:24But the risk still overall is pretty
  • 35:26low that you will have any major injury
  • 35:28to the nerves or any or development of
  • 35:31permanent hypocalcemia in those settings.
  • 35:33And I would also argue that with
  • 35:35the proper subtotal resection,
  • 35:36the recurrence rate should be low,
  • 35:38should be like less than 5%.
  • 35:40So it should be pretty rare that a
  • 35:42person who has undergone A subtotal
  • 35:44resection ever has a recurrence again.
  • 35:46In the event that they do so,
  • 35:47sometimes we have younger patients
  • 35:49in their 30s or so and then they,
  • 35:52they had a subtotal resection
  • 35:53performed adequately and for many,
  • 35:55many years they had normal
  • 35:57parathyroid function,
  • 35:58normal calcium normal PTH levels and
  • 36:00lo and behold, 2030 years later,
  • 36:02they're now in their 60s or 70s and
  • 36:04they have recurrence of disease.
  • 36:06That remnant gland usually is large
  • 36:08enough to be seen on imaging,
  • 36:10but more importantly,
  • 36:11it should be documented in their original
  • 36:14surgical report where that gland was located.
  • 36:16And also what I do when I leave a remnant
  • 36:19is I leave a a titanium clip in that area.
  • 36:22So that's how I resect that tissue.
  • 36:24I resect the portion of parathyroid
  • 36:26tissue that is away from where the
  • 36:27vascular supply is coming in so that I
  • 36:29know that I'm preserving the vascular supply.
  • 36:31And I leave a little clip so that in
  • 36:33the event that a recurrence occurs,
  • 36:35either I or some other surgeon,
  • 36:37if you know down the line I move
  • 36:38or the patient moves somewhere
  • 36:39else that there's a target to know
  • 36:41the clip is in this area.
  • 36:43So that's where that remaining
  • 36:44one gland is left behind.
  • 36:45But it is very rare for a patient to
  • 36:48undergo a subtotal parathyroid resection
  • 36:50for primary hyperparathyroidism to then
  • 36:52have a recurrence that requires reoperation
  • 36:58auto transplantation where you cryo
  • 37:00preserve tissue and reimplant it.
  • 37:02The success rates of that tissue functioning
  • 37:05again is is variable and and low,
  • 37:08you know about 30% or less.
  • 37:10So there are not many centers
  • 37:11here in the United States that
  • 37:13cryopreserve and auto transplant
  • 37:15tissue parathyroid tissue for those
  • 37:17reasons there's no guarantee that
  • 37:19that tissue will take down the line,
  • 37:21but there are some centers that do it.
  • 37:23We don't do that here.
  • 37:30What is the expected recovery time and issues
  • 37:33from a three gland hyperplasia reception?
  • 37:37I was told I'm biochemically cured
  • 37:39but I have residual symptoms,
  • 37:41especially anxiety,
  • 37:42depression, helplessness.
  • 37:43So this brings me back to you know
  • 37:46the reasons why I usually don't
  • 37:49operate on normal calcemic primary
  • 37:51hyperpara when the patient solely
  • 37:54has neurocognitive symptoms, right?
  • 37:56Because neurocognitive symptoms can be
  • 37:58caused by many different reasons and
  • 38:01not always are solely due and often are
  • 38:03not solely due to parathyroid disease.
  • 38:06So you have to manage expectations if if is.
  • 38:10And so I'm always honest with my
  • 38:12patients and I say that the cholyuria,
  • 38:14if you have frequent urination,
  • 38:15that's usually one of the first
  • 38:17symptoms that clears up after
  • 38:18successful parathyroid surgery.
  • 38:19And that's usually in a matter of days
  • 38:21where patients the day after surgery
  • 38:22say that they noticed that they didn't
  • 38:23have to get up multiple times to go pee
  • 38:25and go use the bathroom and they're
  • 38:28very relieved from that bone improvement.
  • 38:31So increase in bone,
  • 38:33bone density,
  • 38:33we can quantify that over time.
  • 38:35So patients have osteopenia preoperatively
  • 38:38or osteoporosis preoperatively and then we
  • 38:41have successful parent thyroid surgery.
  • 38:43Those patients go on to have bone
  • 38:45density testing usually a year
  • 38:47later from their surgery and we see
  • 38:49quantifiable evidence of increased
  • 38:50bone density sometimes the often
  • 38:52times the osteopenia is now back
  • 38:54to normal bone density.
  • 38:56But even in the setting of osteoporosis,
  • 38:58there's an improvement in the bone density.
  • 38:59So those are quantifiable measures.
  • 39:01The neurocognitive symptoms,
  • 39:02there are some people who definitely
  • 39:04feel that their minds are sharper,
  • 39:05their memory is better,
  • 39:06the anxiety has gotten better,
  • 39:08the depression has resolved
  • 39:10or significantly improved.
  • 39:11But that happens very gradually
  • 39:14in some patients.
  • 39:16Some it happens overnight,
  • 39:17but in general,
  • 39:18it's a more prolonged improvement
  • 39:20of those symptoms over time.
  • 39:22And often times,
  • 39:23they're patients who don't notice any
  • 39:26significant improvement of those symptoms.
  • 39:28So you just have to manage expectations
  • 39:29and be honest with patients
  • 39:31about what you think is likely
  • 39:32to improve and what can improve,
  • 39:34but what can also be multifactorial.
  • 39:37And so I think this is the case
  • 39:39where this patient may have other
  • 39:40reasons to have ongoing anxiety,
  • 39:42depression and feelings of
  • 39:44helplessness that are not solely
  • 39:46explained by parathyroid disease.
  • 39:50Let's see here
  • 39:54for second parathyroid surgeries, i.e.
  • 39:57looking for a 5th gland
  • 39:59IS4DC to the gold standard.
  • 40:00I would say there is no gold
  • 40:03standard in terms of imaging
  • 40:05studies in the reoperative setting.
  • 40:08What we do want to say is we definitely
  • 40:10want to have a targetable gland to go for.
  • 40:13So whatever imaging study gets you to
  • 40:15that targetable gland is what's ideal.
  • 40:17And so by that,
  • 40:18I mean there are cases where patients
  • 40:20who have never had surgery but they
  • 40:22have confirmed parathyroid disease
  • 40:23and we send them for imaging and
  • 40:26ultrasound assess to maybe a 4D
  • 40:27CT and none of the imaging clearly
  • 40:30shows abnormal parathyroid tissue.
  • 40:32I still offer those patients surgery
  • 40:34and that is because number one,
  • 40:36I know that they have parathyroid
  • 40:37disease based on their biochemistry.
  • 40:39And #2,
  • 40:39I'm experienced enough that I know
  • 40:41where to look for the normal in the
  • 40:44normal locations where parathyroid
  • 40:45gland should be and in ectopic or
  • 40:47abnormal locations like in the thymus,
  • 40:48in the thyroid along the carotid
  • 40:51sheet or behind the esophagus.
  • 40:53And so I feel confident that I
  • 40:54can find that gland even when
  • 40:56the imaging doesn't show me in
  • 40:58advance of where it should be.
  • 40:59No, in the reoperative setting,
  • 41:00that's a different story.
  • 41:02That patient has had some parathyroid tissue
  • 41:04removed already from a prior surgery.
  • 41:05And whether that surgery was
  • 41:07successful and they had a recurrence
  • 41:08or that that surgery was unsuccessful
  • 41:10and they had persistent disease,
  • 41:12the anatomy now has been destroyed.
  • 41:14There's scar tissue that has formed.
  • 41:16I'm not sure that, you know,
  • 41:18the particular surgeon may have said
  • 41:19they removed the left upper gland,
  • 41:20but they could have mistaken it and
  • 41:22it really was a left lower gland.
  • 41:24So in those cases,
  • 41:25yes,
  • 41:25I want to get some preoperative
  • 41:27imaging that shows me,
  • 41:29gives me a strong indication where
  • 41:32the aberrant overactive land remains
  • 41:33and often times it's in a normal
  • 41:36location in the neck that just got missed.
  • 41:38So for me the reoperative imaging
  • 41:41studies that I send patients for
  • 41:43is usually a 4D CT and that shows
  • 41:46structurally where abnormal parent
  • 41:48thyroid tissue and and instead of the
  • 41:51ultrasound I often get a a functional test.
  • 41:53It says to me be a nuclear medicine test
  • 41:56because that shows functionally that
  • 41:57can show functionally where hyperactivity
  • 41:59of parathyroid tissue resides.
  • 42:01And so I'd like to see that the
  • 42:04cestamebe correlates with the 4D
  • 42:05CT before ioffer patients remedial
  • 42:07surgery or secondary surgery.
  • 42:15See. So I think we've touched on all
  • 42:18of the main questions here and I
  • 42:22don't want to belabor the time here.
  • 42:24So again, I want to thank you all for
  • 42:27inviting me to give a talk on parathyroid
  • 42:30disease and thank you for sending
  • 42:32in such very thoughtful questions.
  • 42:33I thank you to Rochelle and I will
  • 42:36make sure that this is available
  • 42:37for your group and don't hesitate to
  • 42:40contact me anytime in the future.
  • 42:41All right.
  • 42:42So thanks again for the opportunity.
  • 42:43Have a wonderful day. I'm
  • 42:49a.